13.67
price down icon4.47%   -0.64
after-market Handel nachbörslich: 13.87 0.20 +1.46%
loading

Finanzdaten der Denali Therapeutics Inc-Aktie (DNLI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
14.54
- 1.267 294.12 35.14
Operating Expenses
0.24%
132.25
132.57 115.06 123.64 155.96
Benefits Costs and Expenses
116.34
- - - -
Costs And Expenses
0.24%
132.25
132.57 115.06 123.64 155.96
Operating Income/Loss
11.21%
-117.72
-132.57 -113.80 170.48 -120.81
Income/Loss From Continuing Operations Before Tax
-101.80
- 1.267 294.12 35.14
Income/Loss From Continuing Operations After Tax
14.79%
-101.80
-119.47 -99.35 183.38 -109.78
Net Income/Loss
14.79%
-101.80
-119.47 -99.35 183.38 -109.78
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
50,597%
149.40
0.2947 137.64 137.05 136.52
Diluted Average Shares
50,597%
149.40
0.2947 137.64 140.93 136.52
Basic Earnings Per Share
21.84%
-0.68
-0.87 -0.72 1.34 -0.80
Diluted Earnings Per Share
21.84%
-0.68
-0.87 -0.72 1.30 -0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):